Selank Research Guide: Tuftsin Analog Biology, GABA Research, and Evidence Limits
Selank Research Guide: Tuftsin Analog Biology, GABA Research, and Evidence Limits
A plain-English evidence map for Selank, including GABA-related gene expression, rat hippocampal electrophysiology, stress models, and procurement questions.
Understanding Selank without overclaiming
Selank is the seven-residue peptide Thr-Lys-Pro-Arg-Pro-Gly-Pro, developed from the endogenous tetrapeptide tuftsin with a Pro-Gly-Pro extension. Research has examined neurotransmitter-related gene expression, inhibitory synaptic currents, serotonin metabolism, and behavior in rat stress or withdrawal models.
The evidence does not support reducing Selank to a single proven receptor mechanism. GABA-related findings include gene-expression changes and hippocampal-slice electrophysiology, while other studies point to serotonin and neurotrophin-linked measures. These are model-dependent signals.
Product copy should distinguish parent Selank from N-acetyl or amidated variants. Shared core sequence does not establish equivalent pharmacology, purity, or stability.
What researchers are trying to understand
What is Selank?
Selank is a synthetic tuftsin-derived heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. The cited literature is concentrated in animal and ex vivo research.
Does Selank act like a benzodiazepine?
Some rat studies investigated GABAergic overlap, but that does not make Selank a benzodiazepine or establish equivalent receptor action, efficacy, or safety.
What endpoints have been studied?
Researchers have measured gene expression, inhibitory synaptic currents, monoamine metabolism, and behavior in defined rat models. These endpoints should remain tied to those models.
Notable studies, in plain English
The studies below are separated by model and design so that early laboratory signals are not confused with evidence from people.
Experimental optimization of learning and memory processes by Selank
- Model
- Rat
- Design
- Wistar-rat learning experiment with measurements of brain serotonin metabolism.
What the paper reported: The paper reported behavioral and region-specific serotonin-metabolism changes during the tested learning paradigm.
Important limit: A conditioned-reflex experiment in rats does not demonstrate learning, memory, or mood effects in humans.
Selank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission
- Model
- Rat
- Design
- Real-time PCR analysis of 84 neurotransmission-related genes in rat frontal cortex after Selank or GABA exposure.
What the paper reported: The authors reported time-dependent expression changes across GABAergic and other neurotransmission genes.
Important limit: Gene-expression similarity is not proof of direct receptor binding or a human anxiolytic outcome.
Effect of Selank on Spontaneous Synaptic Activity of Rat Hippocampal CA1 Neurons
- Model
- Ex vivo rat
- Design
- Electrophysiology in rat hippocampal slices measuring spontaneous inhibitory postsynaptic currents in CA1 pyramidal neurons.
What the paper reported: Selank changed inhibitory-current amplitude and discharge rate in the tested slices.
Important limit: An isolated-tissue response does not establish behavior, clinical efficacy, or systemic safety.
Peptide Selank Enhances the Effect of Diazepam in Reducing Anxiety in Unpredictable Chronic Mild Stress Conditions in Rats
- Model
- Rat
- Design
- Behavioral comparison of Selank, diazepam, and their combination in control and chronic-mild-stress conditions.
What the paper reported: The authors reported treatment- and stress-dependent changes in elevated-plus-maze measures.
Important limit: The endpoint is an anxiety-like rat behavior and should not be translated into a treatment claim.
Selank, a Peptide Analog of Tuftsin, Attenuates Aversive Signs of Morphine Withdrawal in Rats
- Model
- Rat
- Design
- Naloxone-precipitated morphine-withdrawal model in outbred rats.
What the paper reported: The paper reported changes in a composite withdrawal score and selected behaviors.
Important limit: This is a specific animal-dependence model, not evidence for treating withdrawal or anxiety in people.
What the evidence does—and does not—establish
The mapped literature is predominantly rat or ex vivo research. Behavioral labels such as anxiety-like or learning should not be rewritten as diagnoses or promised effects in people.
GABA-related gene expression and synaptic-current changes do not establish a single molecular target. Direct binding, exposure-response, and independent human replication remain important gaps.
Parent Selank evidence does not automatically apply to N-acetyl Selank, Selank amidate, or other modified materials.
- Selank is a defined tuftsin-derived heptapeptide.
- GABA-related evidence includes rat gene expression and slice electrophysiology.
- Behavioral findings come from specific animal models.
- Modified Selank derivatives need their own evidence.
- Lot testing and literature evidence answer different questions.
Where to buy Selank for laboratory research in the USA
A laboratory listing should disclose the exact seven-residue sequence and whether any terminal modification is present. The product page should pair the lot number with analytical identity and purity evidence, not a generic sample certificate.
Review the observed mass, purity chromatogram, test date, labeled quantity, storage documentation, fulfillment origin, and support contact. Search terms such as buy or where to buy should lead to research-only procurement information, not human-use instructions.
Searches such as “where to buy Selank,” “buy Selank USA,” and “USA peptides” should be treated as laboratory-sourcing questions. Compare U.S. research suppliers by lot traceability, identity testing, quantitative-content information, analytical methods, and stated research-use restrictions—not by implied human outcomes.
Selank research FAQ
Is Selank a GABA-A receptor drug?
The cited studies show GABA-related gene-expression and electrophysiology findings, but they do not establish a complete receptor-level mechanism equivalent to an approved GABAergic drug.
Are Selank's human effects proven?
Not by the evidence mapped here. Most selected primary studies are rat or ex vivo experiments.
Is N-acetyl Selank the same as Selank?
No automatic equivalence should be assumed. A modified peptide is a different test article and needs matching analytical and primary evidence.
What should a Selank COA include?
It should be lot-specific and show identity, observed mass, chromatographic purity, test date, and responsible testing method or laboratory.
Primary references
References link to the original journal record or publisher page. Inclusion is not an endorsement of a product or a clinical conclusion.
- Semenova TP et al. Eksp Klin Farmakol. 2010;73(8):2-5. PMID 20919548.
- Volkova A et al. Frontiers in Pharmacology. 2016;7:31. PMID 26924987. DOI 10.3389/fphar.2016.00031.
- Povarov IS et al. Bulletin of Experimental Biology and Medicine. 2017;162:640-642. PMID 28361410. DOI 10.1007/s10517-017-3676-3.
- Kasian A et al. Behavioural Neurology. 2017;2017:5091027. PMID 28280289. DOI 10.1155/2017/5091027.
- Konstantinopolsky MA et al. Bulletin of Experimental Biology and Medicine. 2022;173:730-733. PMID 36322304. DOI 10.1007/s10517-022-05624-x.